Search Results - Marjolein S. de Bruin-Weller

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry

    Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry by Florence Vroman, Lisa P. van der Rijst, Octavian I. Bacoş-Cosma, Nicolaas P. A. Zuithoff, Marijke Kamsteeg, Paula P. M. van Lumig, Laura Loman, Marie-Louise L. A. Schuttelaar, Marjolein S. de Bruin-Weller, Marlies de Graaf

    Published 2025-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol

    European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in pat... by Matthias Augustin, Hilde Lapeere, Anthony Bewley, Christian Vestergaard, Thomas Werfel, Eric Massana, Ismail Kasujee, Marie-Charlotte Brüggen, Marjolein S de Bruin-Weller, Khaled Ezzedine, Silvia M Ferrucci, Spyridon Gkalpakiotis, Pedro Herranz, Emma K Johansson, Tomáš Kampe, Franz J Legat, Eva Maria Rehbinder, Jacek C Szepietowski, Tiago Torres, Arnau Domenech, Volker Koscielny, Siva Narayanan, Jan Gutermuth

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: